Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pan-genome Analysis of Neuroblastoma by Comparative Genomic Hybridization and Correlation With Pathology for the Diagnostic and the Prognostic Classification

NCT02864563 is registered in ClinicalTrials.gov with Institut Curie as lead sponsor.

NCT NCT02864563
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02864563 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pan-genome Analysis of Neuroblastoma by Comparative Genomic Hybridization and Correlation With Pathology for the Diagnostic and the Prognostic Classification
Lead sponsor
Institut Curie
Phase
Not applicable
Overall status
Completed
Start date
October 4, 2008
Completion date
July 31, 2023
Enrollment
560 (actual)
Sites
27

Conditions

As the registry lists them; a condition with its own page is linked.

neuroblastoma